Cite

HARVARD Citation

    Tanaka, H. et al. (n.d.). P-073 Long-Term Outcomes of Switching from Infliximab to Adalimumab for Japanese Patients with Crohn's Disease Whose Infliximab Treatment Failed. Inflammatory bowel diseases. p. . [Online]. 
  
Back to record